Tea Party Patriots Ordinary citizens reclaiming America's founding principles.
Showing posts with label Rochelle Walensky. Show all posts
Showing posts with label Rochelle Walensky. Show all posts

Sunday, September 25, 2022

The Next in the Endless Line of Boosters: Buyer Beware

 

Deborah Birx (Scarf Lady) Meme via BookwormRoom


Frank Camp at The Daily Wire reports:

Fewer than 2% of eligible Americans have elected to receive a new COVID booster shot, according to CDC data.

While more than 4.4 million Americans have received a “bivalent” COVID booster shot, only 1.5% of people for whom the shot is available have actually gotten it since the CDC started recommending it several weeks ago. The latest COVID vaccine booster is designed with Omicron sub-variants BA.4 and BA.5 in mind.

The CDC’s COVID vaccine tracker shows that 67.8% of the U.S. population who are eligible for the vaccine have completed the primary series of shots. The Bloomberg tracker shows that 32.5% have received at least one booster.

On September 1, CDC Director Dr. Rochelle Walensky recommended the booster, providing the following statement: “The updated COVID-19 boosters are formulated to better protect against the most recently circulating COVID-19 variant. They can help restore protection that has waned since previous vaccination and were designed to provide broader protection against newer variants. This recommendation followed a comprehensive scientific evaluation and robust scientific discussion. If you are eligible, there is no bad time to get your COVID-19 booster and I strongly encourage you to receive it.”

As the CDC and many public health officials are recommending booster shots, the White House is dealing with an unforced crisis regarding COVID after President Joe Biden said that the pandemic was “over” during a recent “60 Minutes” interview. . . .

Read the rest of the report here. 

RELATED: At The Daily Mail: FDA vaccine adviser warns healthy young people should NOT get new COVID booster: Says it's 'unfair to make them take a risk' after data suggested shot was not as effective as first batch

# # #